UA73763C2 - Carbohydrate composition containing prebiotic for treatment or prevention of measles - Google Patents

Carbohydrate composition containing prebiotic for treatment or prevention of measles Download PDF

Info

Publication number: UA73763C2
Authority: UA; Ukraine
Prior art keywords: composition; composition according; prebiotic; milk; agent
Prior art date: 2000-03-01

Application number

UA2002097766A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-01

Filing date

2001-02-14

Publication date

2005-09-15

2001-02-14 Application filed by Nestle Sa filed Critical Nestle Sa

2005-09-15 Publication of UA73763C2 publication Critical patent/UA73763C2/uk

Links

239000000203 mixture Substances 0.000 title claims abstract description 82
235000013406 prebiotics Nutrition 0.000 title claims abstract description 41
201000005505 Measles Diseases 0.000 title claims abstract description 19
230000002265 prevention Effects 0.000 title claims description 7
150000001720 carbohydrates Chemical class 0.000 title description 7
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical class OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 11
229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 11
239000003795 chemical substances by application Substances 0.000 claims description 21
229920001202 Inulin Polymers 0.000 claims description 16
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 16
229940029339 inulin Drugs 0.000 claims description 16
235000013336 milk Nutrition 0.000 claims description 12
239000008267 milk Substances 0.000 claims description 12
210000004080 milk Anatomy 0.000 claims description 12
239000000047 product Substances 0.000 claims description 12
235000013305 food Nutrition 0.000 claims description 11
235000011868 grain product Nutrition 0.000 claims description 8
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
229920001542 oligosaccharide Polymers 0.000 claims description 6
150000002482 oligosaccharides Chemical class 0.000 claims description 6
235000013350 formula milk Nutrition 0.000 claims description 5
239000006041 probiotic Substances 0.000 claims description 5
230000000529 probiotic effect Effects 0.000 claims description 5
235000018291 probiotics Nutrition 0.000 claims description 5
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
229930006000 Sucrose Natural products 0.000 claims description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
239000008103 glucose Substances 0.000 claims description 4
239000008101 lactose Substances 0.000 claims description 4
239000000843 powder Substances 0.000 claims description 4
239000005720 sucrose Substances 0.000 claims description 4
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
229920002488 Hemicellulose Polymers 0.000 claims description 3
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
229920002472 Starch Polymers 0.000 claims description 3
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
235000013351 cheese Nutrition 0.000 claims description 3
239000008107 starch Substances 0.000 claims description 3
235000019698 starch Nutrition 0.000 claims description 3
229920001221 xylan Polymers 0.000 claims description 3
150000004823 xylans Chemical class 0.000 claims description 3
235000013618 yogurt Nutrition 0.000 claims description 3
235000015140 cultured milk Nutrition 0.000 claims description 2
239000013589 supplement Substances 0.000 claims 2
235000011617 hard cheese Nutrition 0.000 claims 1
235000015243 ice cream Nutrition 0.000 claims 1
239000006194 liquid suspension Substances 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
238000002255 vaccination Methods 0.000 abstract description 19
230000028993 immune response Effects 0.000 abstract description 16
235000016709 nutrition Nutrition 0.000 abstract description 15
235000013339 cereals Nutrition 0.000 description 10
230000008901 benefit Effects 0.000 description 6
235000014633 carbohydrates Nutrition 0.000 description 6
230000002708 enhancing effect Effects 0.000 description 6
239000003925 fat Substances 0.000 description 6
235000019197 fats Nutrition 0.000 description 6
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
235000009508 confectionery Nutrition 0.000 description 4
235000015872 dietary supplement Nutrition 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
229940126601 medicinal product Drugs 0.000 description 4
238000000034 method Methods 0.000 description 4
235000018102 proteins Nutrition 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
229960005486 vaccine Drugs 0.000 description 4
235000010469 Glycine max Nutrition 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000037213 diet Effects 0.000 description 3
235000021245 dietary protein Nutrition 0.000 description 3
230000036541 health Effects 0.000 description 3
238000002649 immunization Methods 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
240000002791 Brassica napus Species 0.000 description 2
235000004977 Brassica sinapistrum Nutrition 0.000 description 2
108010011756 Milk Proteins Proteins 0.000 description 2
102000014171 Milk Proteins Human genes 0.000 description 2
206010037660 Pyrexia Diseases 0.000 description 2
108010073771 Soybean Proteins Proteins 0.000 description 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
235000021152 breakfast Nutrition 0.000 description 2
235000008504 concentrate Nutrition 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
235000013365 dairy product Nutrition 0.000 description 2
235000013325 dietary fiber Nutrition 0.000 description 2
229930182830 galactose Natural products 0.000 description 2
239000000787 lecithin Substances 0.000 description 2
235000010445 lecithin Nutrition 0.000 description 2
229940067606 lecithin Drugs 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000009115 maintenance therapy Methods 0.000 description 2
229940041323 measles vaccine Drugs 0.000 description 2
235000021239 milk protein Nutrition 0.000 description 2
230000035764 nutrition Effects 0.000 description 2
229940108461 rennet Drugs 0.000 description 2
108010058314 rennet Proteins 0.000 description 2
239000007787 solid Substances 0.000 description 2
235000021055 solid food Nutrition 0.000 description 2
229940001941 soy protein Drugs 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
235000019737 Animal fat Nutrition 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
235000007558 Avena sp Nutrition 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
108010082495 Dietary Plant Proteins Proteins 0.000 description 1
108010010256 Dietary Proteins Proteins 0.000 description 1
102000015781 Dietary Proteins Human genes 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
239000001422 FEMA 4092 Substances 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
229920002907 Guar gum Polymers 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
108010070551 Meat Proteins Proteins 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
108010084695 Pea Proteins Proteins 0.000 description 1
235000010582 Pisum sativum Nutrition 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
208000036071 Rhinorrhea Diseases 0.000 description 1
206010039101 Rhinorrhoea Diseases 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
102000007544 Whey Proteins Human genes 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
230000009471 action Effects 0.000 description 1
201000009840 acute diarrhea Diseases 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
235000020940 control diet Nutrition 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
208000001848 dysentery Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
235000013376 functional food Nutrition 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000000665 guar gum Substances 0.000 description 1
235000010417 guar gum Nutrition 0.000 description 1
229960002154 guar gum Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000036039 immunity Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
235000014666 liquid concentrate Nutrition 0.000 description 1
229960003213 live attenuated measles Drugs 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
235000021243 milk fat Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
235000019702 pea protein Nutrition 0.000 description 1
239000001814 pectin Substances 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
230000005180 public health Effects 0.000 description 1
206010037844 rash Diseases 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012265 solid product Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
235000021119 whey protein Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Virology (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Dairy Products (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Confectionery (AREA)
Grain Derivatives (AREA)
Jellies, Jams, And Syrups (AREA)

UA2002097766A 2000-03-01 2001-02-14 Carbohydrate composition containing prebiotic for treatment or prevention of measles UA73763C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00200735		2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en)	2000-03-01	2001-02-14	Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number	Publication Date
UA73763C2 true UA73763C2 (en)	2005-09-15

Family

ID=8171132

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2002097766A UA73763C2 (en)	2000-03-01	2001-02-14	Carbohydrate composition containing prebiotic for treatment or prevention of measles

Country Status (21)

Country	Link
US (2)	US20030040492A1 (de)
EP (1)	EP1261355B1 (de)
JP (1)	JP4838477B2 (de)
KR (1)	KR20020081375A (de)
CN (1)	CN1243551C (de)
AR (1)	AR027968A1 (de)
AT (1)	ATE283697T1 (de)
AU (2)	AU2001231746C1 (de)
BR (1)	BR0108828A (de)
CA (1)	CA2400969C (de)
DE (1)	DE60107544T2 (de)
ES (1)	ES2232591T3 (de)
HU (1)	HUP0204546A3 (de)
IL (1)	IL151280A0 (de)
MX (1)	MXPA02008447A (de)
NO (1)	NO20024011D0 (de)
PL (1)	PL365136A1 (de)
PT (1)	PT1261355E (de)
UA (1)	UA73763C2 (de)
WO (1)	WO2001064225A1 (de)
ZA (1)	ZA200207849B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7029702B2 (en) *	1998-07-07	2006-04-18	Ritter Natural Sciences Llc	Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en)	1999-07-23	2001-11-20	Mcdevitt Dennis	System and method for attaching soft tissue to bone
KR20020043078A (ko) *	2000-12-01	2002-06-08	한인규	올리고당이 포함된 복합생균제
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
PL1638416T3 (pl) *	2003-06-23	2013-09-30	Nestec Sa	Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
US20050118299A1 (en) *	2003-12-01	2005-06-02	The Iams Company	Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) *	2003-12-01	2005-06-02	The Iams Company	Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en)	2003-12-01	2005-06-02	The Iams Company	Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) *	2003-12-12	2005-12-19	Nova Biotics As	Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) *	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
US7572474B2 (en)	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) *	2008-10-24	2011-12-13	Mead Johnson Nutrition Company	Nutritional composition with improved digestibility
US8287931B2 (en)	2005-06-30	2012-10-16	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) *	2005-08-19	2012-03-07	理研ビタミン株式会社	脂溶性薬剤組成物
US20080003329A1 (en) *	2006-06-30	2008-01-03	Ricardo Rueda	Enriched infant formulas
WO2008046625A2 (en) *	2006-10-18	2008-04-24	Dsm Ip Assets B.V.	Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) *	2007-02-20	2021-07-29	Vitacare Gmbh & Co. Kg	Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (de) *	2007-08-24	2010-05-26	Barry Callebaut AG	Verfahren und hiermit hergestelltes konfektprodukt
US20110223248A1 (en) *	2007-12-12	2011-09-15	Ritter Pharmaceuticals, Inc.	Methods and compositions for treating lactose intolerance
WO2009151330A1 (en)	2008-06-13	2009-12-17	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section
US20110189148A1 (en) *	2008-06-25	2011-08-04	Ritter Pharmaceuticals, Inc.	Lactose compositions with decreased lactose content
US8986769B2 (en) *	2008-10-24	2015-03-24	Mead Johnson Nutrition Company	Methods for preserving endogenous TGF-β
US8425955B2 (en)	2009-02-12	2013-04-23	Mead Johnson Nutrition Company	Nutritional composition with prebiotic component
SG2014014435A (en)	2009-02-24	2014-07-30	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
US8293264B2 (en) *	2009-05-11	2012-10-23	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
WO2010143940A1 (en)	2009-06-12	2010-12-16	N.V. Nutricia	Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
EP3342413B1 (de)	2009-07-15	2021-10-20	N.V. Nutricia	Fucosyllactose als muttermilchidentisches unverdauliches oligosaccharid zur behandlung und/oder vorbeugung von virus-diarrhöe
MY189329A (en)	2009-07-15	2022-02-04	Nutricia Nv	Mixture of non-digestible oligosaccharides for stimulating the immune system
CN102595934A (zh) *	2009-11-12	2012-07-18	雀巢产品技术援助有限公司	用于促进肠微生物群平衡和健康的营养组合物
WO2011137249A1 (en)	2010-04-28	2011-11-03	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
US20110293784A1 (en)	2010-05-28	2011-12-01	Anja Wittke	Milk-based nutritional compositions
NL2007268C2 (en)	2011-08-16	2013-02-19	Friesland Brands Bv	Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) *	2012-03-28	2015-03-26	Kansas State University Research Foundation	Vaccine adjuvant
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) *	2013-06-17	2013-10-02	中山大学	果糖作为疫苗佐剂的应用
WO2015065194A1 (en)	2013-11-04	2015-05-07	N.V. Nutricia	Fermented formula with non digestible oligosaccharides
CN107921058B (zh) *	2015-08-04	2021-04-16	南方糖业股份公司	菊糖对鼻窦炎的预防作用
WO2019031961A1 (en)	2017-08-11	2019-02-14	N.V. Nutricia	OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
JP2020533291A (ja) *	2017-09-08	2020-11-19	エヴェロバイオサイエンシズ，インコーポレーテッド	プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞
CN111148531A (zh)	2017-09-08	2020-05-12	伊夫罗生物科学公司	细菌胞外囊泡
JP7469037B2 (ja) *	2019-02-28	2024-04-16	森永乳業株式会社	発酵乳
CN111529703B (zh) *	2020-06-17	2023-09-15	湖南循天然营养有限公司	一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113876935B (zh) *	2021-10-19	2025-11-04	深圳市红瑞生物科技有限公司	一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0725683B2 (ja) *	1985-10-31	1995-03-22	ザオ−ストラリアンナシヨナルユニバ−シテイ−	免疫治療方法
US5422346A (en)	1988-01-06	1995-06-06	California Natural Products	Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) *	1993-12-08	1995-06-14	Suedzucker Ag	Hydrierte Fructooligosaccharide
EP0692252B1 (de) *	1994-06-14	2001-04-04	"Raffinerie Tirlemontoise", société anonyme:	Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
ATE169456T1 (de) *	1996-12-23	1998-08-15	Sitia Yomo Spa	Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
US6203797B1 (en)	1998-01-06	2001-03-20	Stephen C. Perry	Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

2001
- 2001-02-14 MX MXPA02008447A patent/MXPA02008447A/es active IP Right Grant
- 2001-02-14 BR BR0108828-9A patent/BR0108828A/pt not_active Application Discontinuation
- 2001-02-14 PT PT01903767T patent/PT1261355E/pt unknown
- 2001-02-14 CN CNB018058973A patent/CN1243551C/zh not_active Expired - Fee Related
- 2001-02-14 WO PCT/EP2001/001627 patent/WO2001064225A1/en not_active Ceased
- 2001-02-14 IL IL15128001A patent/IL151280A0/xx unknown
- 2001-02-14 ES ES01903767T patent/ES2232591T3/es not_active Expired - Lifetime
- 2001-02-14 HU HU0204546A patent/HUP0204546A3/hu unknown
- 2001-02-14 KR KR1020027011308A patent/KR20020081375A/ko not_active Ceased
- 2001-02-14 JP JP2001563122A patent/JP4838477B2/ja not_active Expired - Fee Related
- 2001-02-14 AT AT01903767T patent/ATE283697T1/de not_active IP Right Cessation
- 2001-02-14 AU AU2001231746A patent/AU2001231746C1/en not_active Ceased
- 2001-02-14 DE DE60107544T patent/DE60107544T2/de not_active Expired - Lifetime
- 2001-02-14 PL PL01365136A patent/PL365136A1/xx unknown
- 2001-02-14 EP EP01903767A patent/EP1261355B1/de not_active Expired - Lifetime
- 2001-02-14 CA CA2400969A patent/CA2400969C/en not_active Expired - Fee Related
- 2001-02-14 AU AU3174601A patent/AU3174601A/xx active Pending
- 2001-02-14 UA UA2002097766A patent/UA73763C2/uk unknown
- 2001-03-01 AR ARP010100985A patent/AR027968A1/es not_active Application Discontinuation
2002
- 2002-08-22 NO NO20024011A patent/NO20024011D0/no unknown
- 2002-08-26 US US10/228,722 patent/US20030040492A1/en not_active Abandoned
- 2002-09-30 ZA ZA200207849A patent/ZA200207849B/en unknown
2004
- 2004-04-13 US US10/822,799 patent/US7101553B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2400969A1 (en)	2001-09-07
AR027968A1 (es)	2003-04-16
EP1261355A1 (de)	2002-12-04
EP1261355B1 (de)	2004-12-01
CN1422158A (zh)	2003-06-04
IL151280A0 (en)	2003-04-10
PL365136A1 (en)	2004-12-27
DE60107544D1 (de)	2005-01-05
ES2232591T3 (es)	2005-06-01
DE60107544T2 (de)	2005-12-15
HUP0204546A2 (en)	2003-05-28
NO20024011L (no)	2002-08-22
BR0108828A (pt)	2002-12-10
PT1261355E (pt)	2005-02-28
CN1243551C (zh)	2006-03-01
CA2400969C (en)	2011-04-19
HK1051650A1 (en)	2003-08-15
US7101553B2 (en)	2006-09-05
ATE283697T1 (de)	2004-12-15
NO20024011D0 (no)	2002-08-22
WO2001064225A1 (en)	2001-09-07
ZA200207849B (en)	2003-12-30
AU3174601A (en)	2001-09-12
MXPA02008447A (es)	2002-12-13
AU2001231746B2 (en)	2004-12-23
US20030040492A1 (en)	2003-02-27
JP4838477B2 (ja)	2011-12-14
JP2003533438A (ja)	2003-11-11
KR20020081375A (ko)	2002-10-26
AU2001231746C1 (en)	2005-10-06
HUP0204546A3 (en)	2003-10-28
US20040191234A1 (en)	2004-09-30

Publication	Publication Date	Title
UA73763C2 (en)	2005-09-15	Carbohydrate composition containing prebiotic for treatment or prevention of measles
AU2001231746A1 (en)	2001-11-22	Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
ES2355754T3 (es)	2011-03-30	Composición nutricional.
TWI639387B (zh)	2018-11-01	用於預防胃腸道受傷及／或促進胃腸道治癒之半乳寡糖
RU2740156C1 (ru)	2021-01-12	Способы улучшения роста полезных бактерий в желудочно-кишечном тракте
CN113662199A (zh)	2021-11-19	用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
TW201233334A (en)	2012-08-16	Human milk oligosaccharides to promote growth of beneficial bacteria
TW201429477A (zh)	2014-08-01	使用人乳寡糖之用於調節炎症之營養調配物
TW201304692A (zh)	2013-02-01	增進有益微生物相生長之益生菌及人乳寡醣之合益素（ｓｙｎｂｉｏｔｉｃ）組合
TW201438719A (zh)	2014-10-16	改善壓力症狀之母乳寡糖
TW201438720A (zh)	2014-10-16	增強學習及記憶力之膳食寡糖
RU2695699C2 (ru)	2019-07-25	Питательная композиция с низким содержанием среднецепочечных жирных кислот в определенных соотношениях и ее применение
US20250205261A1 (en)	2025-06-26	Composition for controlling growth of bacteria in the intestinal tract and use thereof
van Leusen et al.	2014	Industrial applications of galactooligosaccharides
RU2694195C2 (ru)	2019-07-09	Питательная композиция для применения при активации формирования и/или регенерации кишечника и/или печени
CN112806577B (zh)	2021-11-26	产丁酸的益生元益生菌增效组合
HK1051650B (en)	2005-05-20	Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
HK40064537A (en)	2022-07-08	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2025005236A1 (ja)	2025-01-02	Ｆｕｓｏｂａｃｔｅｒｉｕｍ属菌の制御用組成物及びその利用
TW201244721A (en)	2012-11-16	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
Veereman-Wauters	2010	Prebiotics as Infant Foods
food Infant et al.	0	25.3 Nutritional benefits of galactooligosaccharides for infants and young children